These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 8014110)
21. Effect of dietary fat on codon 12 and 13 Ha-ras gene mutations in 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced rat mammary gland tumors. Roberts-Thomson SJ; Snyderwine EG Mol Carcinog; 1997 Dec; 20(4):348-54. PubMed ID: 9433479 [TBL] [Abstract][Full Text] [Related]
22. Inhibition of apoptosis in colon tumors induced in the rat by 2-amino-3-methylimidazo[4,5-f]quinoline. Hayashi R; Luk H; Horio D; Dashwood R Cancer Res; 1996 Oct; 56(19):4307-10. PubMed ID: 8813112 [TBL] [Abstract][Full Text] [Related]
23. K-ras mutations in aberrant crypt foci, adenomas and adenocarcinomas during azoxymethane-induced colon carcinogenesis. Vivona AA; Shpitz B; Medline A; Bruce WR; Hay K; Ward MA; Stern HS; Gallinger S Carcinogenesis; 1993 Sep; 14(9):1777-81. PubMed ID: 8403199 [TBL] [Abstract][Full Text] [Related]
24. One dose of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) or 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) induces tumours in Min/+ mice by truncation mutations or LOH in the Apc gene. Andreassen A; Møllersen L; Vikse R; Steffensen IL; Mikalsen A; Paulsen JE; Alexander J Mutat Res; 2002 May; 517(1-2):157-66. PubMed ID: 12034317 [TBL] [Abstract][Full Text] [Related]
25. High frequency and low specificity of ras gene mutations in rat Zymbal's gland tumors induced by 2-amino-3-methylimidazo[4,5-f]quinoline. Takahashi M; Minamoto T; Sugimura T; Esumi H Carcinogenesis; 1993 Jul; 14(7):1355-7. PubMed ID: 8330349 [TBL] [Abstract][Full Text] [Related]
26. Mutational analysis of Ctnnb1 and Apc in tumors from rats given 1,2-dimethylhydrazine or 2-amino-3-methylimidazo[4,5-f]quinoline: mutational 'hotspots' and the relative expression of beta-catenin and c-jun. Blum CA; Tanaka T; Zhong X; Li Q; Dashwood WM; Pereira C; Xu M; Dashwood RH Mol Carcinog; 2003 Apr; 36(4):195-203. PubMed ID: 12669311 [TBL] [Abstract][Full Text] [Related]
27. Mutagenic specificity of 2-amino-3-methylimidazo[4,5-f]quinoline and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in the supF shuttle vector system. Endo H; Schut HA; Snyderwine EG Cancer Res; 1994 Jul; 54(14):3745-51. PubMed ID: 8033094 [TBL] [Abstract][Full Text] [Related]
28. Absence of p53 gene mutations in rat colon carcinomas induced by azoxymethane. Shivapurkar N; Belinsky SA; Wolf DC; Tang Z; Alabaster O Cancer Lett; 1995 Sep; 96(1):63-70. PubMed ID: 7553609 [TBL] [Abstract][Full Text] [Related]
29. The colon carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) is actively secreted in the distal colon of the rat: an integrated view on the role of PhIP transport and metabolism in PhIP-induced colon carcinogenesis. Nicken P; Schröder B; von Keutz A; Breves G; Steinberg P Arch Toxicol; 2013 May; 87(5):895-904. PubMed ID: 23306951 [TBL] [Abstract][Full Text] [Related]
30. Absence of PhIP adducts, p53 and Apc mutations, in rats fed a cooked beef diet containing a high level of heterocyclic amines. Shen CL; Purewal M; San Francisco S; Pence BC Nutr Cancer; 1998; 30(3):227-31. PubMed ID: 9631495 [TBL] [Abstract][Full Text] [Related]
31. Glucuronidation of N-hydroxy heterocyclic amines by human and rat liver microsomes. Kaderlik KR; Mulder GJ; Turesky RJ; Lang NP; Teitel CH; Chiarelli MP; Kadlubar FF Carcinogenesis; 1994 Aug; 15(8):1695-701. PubMed ID: 8055651 [TBL] [Abstract][Full Text] [Related]
32. Metabolic activation of carcinogenic heterocyclic aromatic amines by human liver and colon. Turesky RJ; Lang NP; Butler MA; Teitel CH; Kadlubar FF Carcinogenesis; 1991 Oct; 12(10):1839-45. PubMed ID: 1934265 [TBL] [Abstract][Full Text] [Related]
33. Strong anti-mutagenic activity of the novel lipophilic antioxidant 1-O-hexyl-2,3,5-trimethylhydroquinone against heterocyclic amine-induced mutagenesis in the Ames assay and its effect on metabolic activation of 2-amino-6-methyldipyrido[1,2-a:3',2'-d] imidazole (Glu-p-1). Hirose M; Iwata S; Ito E; Nihro Y; Takahashi S; Mizoguchi Y; Miki T; Satoh T; Ito N; Shirai T Carcinogenesis; 1995 Sep; 16(9):2227-32. PubMed ID: 7554080 [TBL] [Abstract][Full Text] [Related]
34. Mutational analysis of the liver, colon and kidney of Big Blue rats treated with 2-amino-3-methylimidazo[4,5-f]quinoline. Bol SA; Horlbeck J; Markovic J; de Boer JG; Turesky RJ; Constable A Carcinogenesis; 2000 Jan; 21(1):1-6. PubMed ID: 10607726 [TBL] [Abstract][Full Text] [Related]
35. Early detection of 2-amino-1-methyl-6-phenylimidazo (4,5-b)pyridine(PhIP)-induced mutations within the Apc gene of rat colon. Burnouf D; Miturski R; Nagao M; Nakagama H; Nothisen M; Wagner J; Fuchs RP Carcinogenesis; 2001 Feb; 22(2):329-35. PubMed ID: 11181456 [TBL] [Abstract][Full Text] [Related]
36. Synergistic enhancement of hepatic foci development by combined treatment of rats with 10 heterocyclic amines at low doses. Hasegawa R; Miyata E; Futakuchi M; Hagiwara A; Nagao M; Sugimura T; Ito N Carcinogenesis; 1994 May; 15(5):1037-41. PubMed ID: 8200065 [TBL] [Abstract][Full Text] [Related]
37. Rat p53 gene mutations in primary Zymbal gland tumors induced by 2-amino-3-methylimidazo[4,5-f]quinoline, a food mutagen. Makino H; Ishizaka Y; Tsujimoto A; Nakamura T; Onda M; Sugimura T; Nagao M Proc Natl Acad Sci U S A; 1992 Jun; 89(11):4850-4. PubMed ID: 1594584 [TBL] [Abstract][Full Text] [Related]
38. Inflammation does not precede or accompany the induction of preneoplastic lesions in the colon of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-fed rats. Kühnel D; Taugner F; Scholtka B; Steinberg P Arch Toxicol; 2009 Aug; 83(8):763-8. PubMed ID: 19212758 [TBL] [Abstract][Full Text] [Related]
39. H-ras oncogene mutations during development of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced rat mammary gland cancer. Yu M; Snyderwine EG Carcinogenesis; 2002 Dec; 23(12):2123-8. PubMed ID: 12507937 [TBL] [Abstract][Full Text] [Related]
40. Altered gene expression in rat colonic adenocarcinomas induced in an azoxymethane plus 2-amino-1-methyl-6-phenylimidazo[4,5-b]- pyridine initiation-promotion model. Doi K; Hagihara A; Wei M; Yunoki T; Fukushima S; Wanibuchi H Oncology; 2007; 73(3-4):252-60. PubMed ID: 18424890 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]